sglt2 inhibitors vs glp-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes Renal outcomes of SGLT2 inhibitors

Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats

The most detailed population-level analysis comes from Wharton et al., published in Diabetes, Obesity and Metabolism in 2021, which pooled data from the STEP 13 trials

Benefits of the maintenance approach include sustained appetite regulation, continued metabolic support, fewer side effects at lower doses, and easier dose escalation if weight begins to creep

Fisher starts by explaining what GLP-1s are and how they work

Diabetes Obes Metab (2018) 20:46873

LY3437943 demonstrated a safety and tolerability profile equivalent to other incretins in a phase 1 single ascending dosage study